Skip to content

Systemic Effect of Periodontal Therapy on Risk Markers of Acute Cardiovascular Events

Systemic Effect of Periodontal Therapy on Risk Markers of Acute Cardiovascular Events

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-66tr7h
Enrollment
Unknown
Registered
2020-06-24
Start date
2017-04-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Interventions

Experimental group A: 30 patients with periodontitis and without systemic diseases will receive non-surgical periodontal treatment in 4 sessions with an interval of 7 days between sessions. Experiment
Procedure/surgery

Sponsors

Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo
Lead Sponsor
Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients will be selected based on the free demand of the Graduate Clinic of the Faculty of Dentistry of Ribeirão Preto. Sixty patients will be invited to participate in the study and will sign an informed consent form (TCLE) containing information about the objectives, risks and benefits of the study. All patients should have at least 14 natural teeth, at least 4 of them molars with at least 4 pockets with probing pocket depth greater or equal to 4 mm and 6 sites with clinical attachment level greater than 3 mm.

Exclusion criteria

Exclusion criteria: Patients with chronic inflammation or immunological conditions, such as arthritis, heart and kidney disease, smoking history, pregnancy and use of medication such as anti-inflammatories, antibiotics, immunosuppressants, or anticoagulants, will be excluded. Patients who withdraw from participating in the survey or who are unable to attend scheduled appointments will be excluded from the study, but they will continue to receive the necessary periodontal treatment. Special care will be taken for cardiac evaluation. The risk of cardiovascular events will be assessed previously in all patients selected according to the Brazilian Cardiology Association, where factors such as smoking, hypertension, overweight/ obesity, dyslipidemia, regular physical activity and psychosocial factors are evaluated (Simão et al., 2014). Patients who come into the medium or high-risk categories will be excluded from the study and instructed to look for specialized medical care.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of non-surgical periodontal treatment performed in a single or multiple sessions on risk biomarkers for acute cardiovascular events and sepsis through immunoenzymatic assays.

Secondary

MeasureTime frame
Evaluate periodontal clinical parameters with a complete periodontal screening(probing depth mm- PD, clinical attachment loss mm- CAL, bleeding on probing %- BOP and plaque index % - PI) before and after basic periodontal therapy in normosystemic patients diagnosed with periodontitis. ;Evaluate and quantify the biomarkers (procalcitonin, copeptin, BNP, NT-proBNP, IL-6, TNF-alfa and c-reactive protein) in three moments: before periodontal therapy and after 24 and 48 hours of periodontal therapy through immunoenzymatic assays.;Set a plausibility of the systemic risk of periodontal treatment and, based on the biological events triggered and proven by the immunoenzymatic results of the biomarkers and the statistical analysis of these results through non-parametric tests, suggest less invasive approaches to minimize the risk and protect the patient..

Countries

Brazil

Contacts

Public ContactCatarina Tahim

Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo

c.tahim16@usp.nr+55 085 98723-5338

Outcome results

None listed

Source: REBEC (via WHO ICTRP)